Related Experiment Videos
HLA-DRB1 compatibility in cadaver kidney transplantation: correlation with graft survival and function
F Poli1, L Mascaretti, M Pappalettera
1Centro Trasfusionale e di Immunologia dei Trapianti, Ospedale Maggiore Policlinico, Milano, Italy.
Insights
Optimizing kidney transplant outcomes hinges on human leukocyte antigen (HLA)-DRB1 matching. Better HLA-DRB1 compatibility significantly improves graft survival and reduces rejection episodes in cadaver kidney transplants.
Area of Science:
- Nephrology
- Immunology
- Transplantation Science
Background:
- Genomic human leukocyte antigen (HLA) typing, particularly for HLA-DR, prompts re-evaluation of HLA-DR compatibility in cadaver kidney transplantation.
- Previous assessments of HLA matching primarily focused on HLA-A and HLA-B loci.
Purpose of the Study:
- To investigate the impact of HLA-DRB1 matching on kidney graft survival, rejection episodes, and renal function.
- To compare the significance of HLA-DRB1 matching against other factors like HLA-A,B matching, donor age, and pre-transplant characteristics.
Main Methods:
- Retrospective analysis of 416 cadaver kidney transplant recipients.
- Univariate and Cox regression analyses were employed to assess graft survival.
- Evaluated rejection episodes and creatinine levels at 3 months post-transplant for a subset of 198 recipients.
Main Results:
- Twenty-four month graft survival rates were 100% (0 mismatches), 87.9% (1 mismatch), and 81.3% (2 mismatches).
- HLA-DRB1 matching emerged as the most significant factor for graft survival (P=0.001), followed by HLA-A,B matching (P=0.02) and donor age (P=0.04).
- Zero HLA-DRB1 mismatches correlated with significantly fewer rejection episodes (92% vs. 62% and 41%) and lower mean creatinine levels (1.2 mg/dl vs. 1.4 and 1.5 mg/dl).
Conclusions:
- HLA-DRB1 compatibility is a critical determinant of long-term graft survival and reduced rejection in kidney transplantation.
- These findings suggest HLA-DRB1 matching should be considered a key criterion for organ allocation in cadaver kidney transplants.
- Prospective studies are recommended to validate these significant associations.
Abstract:
The introduction of genomic HLA-DR typing has stimulated a re-evaluation of the role of HLA-DR compatibility on cadaver kidney transplantation. We retrospectively studied the influence of HLA-DRB1 matching on the survival of 416 patients using univariate and Cox regression analysis as well as its influence on the occurrence of rejection episodes and on creatinine level at the 3rd month in the 198 recipients for whom these data were available. The following parameters were also considered: HLA-A,B compatibility, donor and recipient age, graft number, pre-transplant blood transfusions and panel reactive antibodies (PRA). Twenty-four month graft survival was 100% for transplants with zero mismatches (n = 47), 87.9% for those with one mismatch (n = 191) and 81.3% for those with two mismatches (n = 178). In the Cox model, HLA-DRB1 matching was the most significant variable influencing graft survival (47% of chi 2 P = 0.001), followed by HLA-A,B matching (23%, P = 0.02) and donor age (19%, P = 0.04). Ninety-two percent of the patients with zero mismatches experienced no rejection episodes in the first 3 posttransplant months compared with 62% and 41% of patients with one and two mismatches, respectively. Mean creatinine level (mg/dl) was 1.2, 1.4, and 1.5 in patients with zero, one, and two mismatches, respectively. Should these results be confirmed by prospective studies, HLA-DRB1 compatibility will have to be considered as an organ allocation criterion.